Revenue
2011
2012
2013
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.5M | $26.4M | $21.0M | $24.9M | $22.4M | — | $7.3M | $5.8M | $1.4M | $1.1M |
| Gross profit | — | $3.0M | $1.8M | $3.0M | $1.8M | — | $3.2M | $3.0M | $959,054 | $842,315 |
| Research & development | — | — | — | — | — | — | — | $64,386 | $93,489 | $73,655 |
| Operating expenses | $6.3M | $6.4M | $4.2M | $3.1M | $1.7M | $21,387 | $8.0M | $4.0M | $2.1M | $685,208 |
| Operating income | −$3.1M | −$3.4M | −$2.4M | −$82,311 | $128,038 | −$745,640 | −$4.8M | −$992,131 | −$1.1M | $157,107 |
| EBITDAderived | −$2.8M | −$3.2M | −$2.4M | −$39,384 | — | — | −$4.7M | −$941,366 | −$1.1M | $173,729 |
| Net income | −$487,792 | −$2.3M | $103,615 | −$436,766 | $94,115 | −$21,387 | −$5.5M | −$1.5M | −$1.2M | $142,305 |
| Basic EPSper diluted share | -$0.01 | -$0.02 | $0.00 | -$0.00 | — | -$0.01 | -$0.17 | -$0.04 | -$0.08 | $0.14 |
| Diluted EPSper diluted share | -$0.01 | -$0.02 | $0.00 | -$0.00 | — | -$0.01 | -$0.17 | -$0.04 | -$0.08 | $0.14 |